| Name | Title | Contact Details |
|---|---|---|
Marc Fishman |
Vice President, Deputy General Counsel | Profile |
Brian Donnelly |
Managing Assistant General Counsel | Profile |
Forrester Liddle |
Head of Intellectual Property and Legal for | Profile |
Melissa DeHonney |
Asst. General Counsel - Market Access and Public Affairs | Profile |
Denise Maher |
Managing Assistant General Counsel - Employment Law and EEO Investigations | Profile |
NBMC is a multi-specialty, regional medical center with more than 400 employees and 70 medical providers representing approximately 20 specialties
Savara Inc. is an orphan lung disease company. Savara`s pipeline comprises: Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for PAP, and in Phase 2a development for NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of MRSA infection in cystic fibrosis. Savara`s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. Savara`s management team has significant experience in orphan drug development and pulmonary medicine, in identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.
Alnara Pharmaceuticals, Inc. is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
DSM is active worldwide in life science products, performance materials and industrial chemicals. The group has annual sales of close to EUR 5.6 billion and employs about 18,500 people at more than 200 sites across the world. DSM ranks among the global
CRB is a Oreland, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.